AVITA Medical, Inc. (RCEL) Total Non-Current Liabilities (2018 - 2026)

AVITA Medical (RCEL) has reported Total Non-Current Liabilities for 9 consecutive years, with $74.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Non-Current Liabilities rose 8.19% year-over-year to $74.7 million; the trailing twelve-month figure through Jun 2026 stood at $74.7 million (up 8.19% YoY), and the FY2025 full-year result was $70.0 million, down 2.09% from the prior year.
• Total Non-Current Liabilities rose to $74.7 million in Q2 2026 per RCEL's latest filing, from $70.0 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $74.7 million in Q2 2026 and bottomed at $8.1 million in Q1 2022.
• Historically, Total Non-Current Liabilities has averaged $53.8 million across 5 years, with a median of $65.8 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities dropped 11.18% in 2022, then surged 405.49% in 2023.
• Over 5 years, Total Non-Current Liabilities stood at $11.6 million in 2022, then soared by 405.49% to $58.7 million in 2023, then advanced by 21.8% to $71.5 million in 2024, then slipped by 2.09% to $70.0 million in 2025, then gained by 6.7% to $74.7 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $74.7 million, $70.0 million, and $68.5 million for Q2 2026, Q4 2025, and Q3 2025 respectively.